Status:
UNKNOWN
Estrogen Receptors and Peripheral Artery Disease
Lead Sponsor:
University of Catanzaro
Conditions:
Estrogen Deficiency
Peripheral Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
It is estimated that \>200 million people have Peripheral artery disease (PAD) worldwide. PAD is related to increased morbidity or mortality in affected patients. More severe forms of PAD are surgical...
Detailed Description
PAD is the atherosclerotic obstruction of the arteries of the lower extremities and it is widespread especially in highly developed countries. The most common complication of PAD is critical limb isch...
Eligibility Criteria
Inclusion
- Patients with peripheral artery disease (PAD) eligible to receive arterial reconstructive open surgery.
Exclusion
- malignancy
- estrogen therapy
Key Trial Info
Start Date :
January 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 2 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04419727
Start Date
January 2 2020
End Date
November 2 2020
Last Update
June 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CIFL- Interuniversity Center of Phlebolymphology
Catanzaro, Italy, 88100